Pulmozyme Prices, Coupons and Patient Assistance Programs
Pulmozyme (dornase alfa) is a member of the miscellaneous respiratory agents drug class and is commonly used for Cystic Fibrosis.
Pulmozyme Prices
This Pulmozyme price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Pulmozyme inhalation solution (2.5 mg/2.5 mL) is around $3,436 for a supply of 75 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Inhalation Solution
| Quantity | Per unit | Price |
|---|---|---|
| 75 (30 x 2.5 milliliters) | $45.81 | $3,435.88 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
Print NowThe free Drugs.com Discount Card can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan.
Manufacturer Coupons and Rebates
Pulmozyme offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Pulmozyme Co-Pay Card Program: Eligible patients may receive help with their monthly copays; for additional information contact the program at 877-794-8723.
| Applies to: | Pulmozyme |
| Number of uses: | Once per month until program expires |
Patient Assistance Programs for Pulmozyme
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Genentech Access to Care Foundation (Pulmozyme)
Elligibility requirements:
- Must have no prescription coverage or been denied coverage
- Gross annual household income at or below $100,000
- Not disclosed
- Must be treated by US licensed healthcare provider
- This is a program for cystic fibrosis patients who are first-time users of Pulmozyme with an on-label diagnosis, or previous users of the medication who are re-initiating therapy and have an on-label diagnosis. The company will offer benefits investigation and copay assistance as well.
Applicable drugs:
- Pulmozyme (dornase alfa) Vial
Provider: HealthWell Foundation Copay Program
Elligibility requirements:
- May have insurance
- Varies
- Medically appropriate condition/diagnosis
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
- Pulmozyme (dornase alfa)
More about Pulmozyme (dornase alfa)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 1 Review – Add your own review/rating
- Drug class: miscellaneous respiratory agents
